AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Letsita-M 50/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Lekasa Health Care Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Letsita-M 50/1000 Tablet

Diabetol Duo 50/1000mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like vision loss and kidney disease, potentially lowering heart attack and stroke risks. Diabetol Duo 50/1000mg may be used alone or with other diabetes treatments, optimally alongside a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood sugar readings, and other medications. Consuming it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinue only under your doctor's guidance. Adherence to your prescribed diet and exercise plan is crucial for optimal diabetes control; lifestyle choices significantly influence management. Common side effects include nausea, diarrhea, vomiting, abdominal discomfort, headache, and sore throat. Low blood sugar (hypoglycemia) is possible, especially when combined with insulin or sulfonylureas; learn to identify and manage this risk. This medication isn't suitable for everyone. Inform your physician of any pre-existing kidney, liver, heart, or pancreatic issues, or significant alcohol consumption before starting. Pregnant or breastfeeding individuals require medical consultation prior to use. Interactions with other medications are possible; disclose all medications to your doctor. Alcohol should be limited due to its potential to lower blood sugar. Your doctor will monitor kidney function and blood glucose levels throughout your treatment.

Uses of Letsita-M 50/1000 Tablet

Managing type 2 diabetes

Major Benefits of Letsita-M 50/1000 Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Letsita-M 50/1000 Tablet whole; avoid chewing, crushing, or fracturing it. Consume it with a meal.

Common Side effects of Letsita-M 50/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Letsita-M 50/1000 Tablet:

Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Letsita-M 50/1000 Tablets with food.

How Letsita-M 50/1000 Tablet works:

Letsita-M 50/1000 tablets combine sitagliptin and metformin to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action promotes superior blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Letsita-M 50/1000 Tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Letsita-M 50/1000 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Letsita-M 50/1000 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Letsita-M 50/1000 Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Letsita-M 50/1000 Tablets are contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

The use of Letsita-M 50/1000 Tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Letsita-M 50/1000 Tablet :

Should you forget a Letsita-M 50/1000 Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Letsita-M 50/1000 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Letsita-M 50/1000 Tablet

Letsita-M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Letsita-M 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Letsita-M 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Letsita-M 50/1000 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Letsita-M 50/1000 tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Letsita-M 50/1000 Tablet. This occurs due to excessive lactic acid buildup in the blood. Because it's rare, metformin is avoided in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Letsita-M and seek immediate medical attention.
Letsita-M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Letsita-M 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Letsita-M 50/1000 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Letsita-M 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Yes, Sitagliptin + Metformin (Letsita-M 50/1000 Tablet) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding its use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Letsita-M 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Letsita-M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Letsita-M 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Letsita-M 50/1000 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Letsita-M 50/1000 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Letsita-M 50/1000 Tablet. This rare complication is why the medication is contraindicated in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Letsita-M 50/1000 Tablet immediately and seek immediate medical attention.
Prolonged Letsita-M 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left untreated. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Letsita-M 50/1000 Tablet
164
MRP 190
13% off